Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Weltrowska

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
European Journal of Medicinal Chemistry|December 21, 2000
Synthesis and in vitro opioid activity profiles of DALDA analoguesP W Schiller, T M Nguyen, I Berezowska, et al.
Journal of Medicinal Chemistry|September 7, 2001
[2',6'-Dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group: potent and selective kappa opioid antagonistsY Lu, T M Nguyen, G Weltrowska, et al.
Biopolymers|May 8, 2000
The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonistsP W Schiller, G Weltrowska, I Berezowska, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|May 30, 1998
The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-related delta-opioid antagonists contains all trans peptide bondsB C Wilkes, T M Nguyen, G Weltrowska, et al.
Journal of Medicinal Chemistry|October 1, 1991
Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificityP W Schiller, G Weltrowska, T M Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1992
Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonistsP W Schiller, T M Nguyen, G Weltrowska, et al.
NIDA Research Monograph|January 1, 1993
The use of conformational restriction and molecular modeling techniques in the development of receptor-specific opioid peptide agonists and antagonistsP W Schiller, T M Nguyen, G Weltrowska, et al.
Journal of Medicinal Chemistry|September 10, 1999
The opioid mu agonist/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in ratsP W Schiller, M E Fundytus, L Merovitz, et al.
Journal of Receptor and Signal Transduction Research|March 11, 1999
Subtleties of structure-agonist versus antagonist relationships of opioid peptides and peptidomimeticsP W Schiller, G Weltrowska, R Schmidt, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Medicinal Chemistry|December 21, 2000
Synthesis and in vitro opioid activity profiles of DALDA analoguesP W Schiller, T M Nguyen, I Berezowska, et al.
Journal of Medicinal Chemistry|September 7, 2001
[2',6'-Dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group: potent and selective kappa opioid antagonistsY Lu, T M Nguyen, G Weltrowska, et al.
Biopolymers|May 8, 2000
The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonistsP W Schiller, G Weltrowska, I Berezowska, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|May 30, 1998
The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-related delta-opioid antagonists contains all trans peptide bondsB C Wilkes, T M Nguyen, G Weltrowska, et al.
Journal of Medicinal Chemistry|October 1, 1991
Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificityP W Schiller, G Weltrowska, T M Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1992
Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonistsP W Schiller, T M Nguyen, G Weltrowska, et al.
NIDA Research Monograph|January 1, 1993
The use of conformational restriction and molecular modeling techniques in the development of receptor-specific opioid peptide agonists and antagonistsP W Schiller, T M Nguyen, G Weltrowska, et al.
Journal of Medicinal Chemistry|September 10, 1999
The opioid mu agonist/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in ratsP W Schiller, M E Fundytus, L Merovitz, et al.
Journal of Receptor and Signal Transduction Research|March 11, 1999
Subtleties of structure-agonist versus antagonist relationships of opioid peptides and peptidomimeticsP W Schiller, G Weltrowska, R Schmidt, et al.
Pageof 2